Preliminary evaluation of the potential of 99mTc carbonyl-DTPA-Rituximab as a tracer for sentinel lymph node detection.

[1]  S. Subramanian,et al.  An indigenous single-vial kit formulation of human serum albumin nanocolloid for use in sentinel lymph node detection. , 2015, Nuclear medicine communications.

[2]  J. Correia,et al.  Comparative biological evaluation of two [99mTc(CO)3]-dextran pyrazolyl mannose conjugates developed for use in sentinel lymph node detection. , 2014, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[3]  G. Samuel,et al.  ⁹⁹mTc carbonyl DTPA-rituximab: preparation and preliminary bioevaluation. , 2014, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[4]  R. Elashoff,et al.  Final trial report of sentinel-node biopsy versus nodal observation in melanoma. , 2014, The New England journal of medicine.

[5]  Yuntao Xie,et al.  Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy. , 2013, Breast.

[6]  J. Correia,et al.  Mannosylated dextran derivatives labeled with fac-[M(CO)₃]+ (M = (99m)Tc, Re) for specific targeting of sentinel lymph node. , 2011, Molecular pharmaceutics.

[7]  K. Lewandowski,et al.  Primary breast lymphoma – a review of the literature and report of three cases , 2011, Archives of medical science : AMS.

[8]  J. Correia,et al.  New 99mTc(CO)3 mannosylated dextrans bearing S-derivatized cysteine chelator , 2010 .

[9]  T. Poli,et al.  Sentinel Node Biopsy in Head and Neck Squamous Cell Cancer: 5-Year Follow-Up of a European Multicenter Trial , 2010, Annals of Surgical Oncology.

[10]  A. Luini,et al.  Sentinel Lymph Node Biopsy in Breast Cancer: Ten-Year Results of a Randomized Controlled Study , 2010, Annals of surgery.

[11]  W. Jennings,et al.  Primary Breast Lymphoma: The Role of Mastectomy and the Importance of Lymph Node Status , 2007, Annals of surgery.

[12]  G. Paintaud,et al.  Pharmacokinetics of rituximab and its clinical use: thought for the best use? , 2007, Critical reviews in oncology/hematology.

[13]  Dong Soo Lee,et al.  Development of 99mTc-neomannosyl human serum albumin (99mTc-MSA) as a novel receptor binding agent for sentinel lymph node imaging , 2004, Nuclear medicine communications.

[14]  M. Brechbiel,et al.  Development of a spectroscopic assay for bifunctional ligand-protein conjugates based on copper. , 2004, Nuclear medicine and biology.

[15]  C K Hoh,et al.  A synthetic macromolecule for sentinel node detection: (99m)Tc-DTPA-mannosyl-dextran. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  R. Schibli,et al.  Influence of the denticity of ligand systems on the in vitro and in vivo behavior of (99m)Tc(I)-tricarbonyl complexes: a hint for the future functionalization of biomolecules. , 2000, Bioconjugate chemistry.

[17]  G. S. Mijnhout,et al.  Radiopharmaceuticals in sentinel lymph-node detection – an overview , 1999, European Journal of Nuclear Medicine.

[18]  Roger Schibli,et al.  A Novel Organometallic Aqua Complex of Technetium for the Labeling of Biomolecules: Synthesis of [99mTc(OH2)3(CO)3]+ from [99mTcO4]- in Aqueous Solution and Its Reaction with a Bifunctional Ligand , 1998 .

[19]  S. Nofech-Mozes,et al.  Sentinel lymph node biopsy vs. pelvic lymphadenectomy in early stage cervical cancer: is it time to change the gold standard? , 2010, Gynecologic oncology.

[20]  D. Eshima,et al.  Radiopharmaceuticals for lymphoscintigraphy: including dosimetry and radiation considerations. , 2000, Seminars in nuclear medicine.

[21]  D. Morton,et al.  The concept of sentinel node localization: how it started. , 2000, Seminars in nuclear medicine.